285 related articles for article (PubMed ID: 22565480)
21. [Candidate patient for treatment with continuous apomorphine infusion].
Martà MJ; Kulisevsky J
Rev Neurol; 2012; 55 Suppl 1():S15-9. PubMed ID: 23169228
[TBL] [Abstract][Full Text] [Related]
22. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
[No Abstract] [Full Text] [Related]
23. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
Nakamura N; Ohyagi Y; Imamura T; Yanagihara YT; Iinuma KM; Soejima N; Murai H; Yamasaki R; Kira JI
J Alzheimers Dis; 2017; 58(4):1151-1161. PubMed ID: 28550243
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
Deleu D; Hanssens Y; Northway MG
Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the clinical pharmacology of Parkinson's disease.
Montastruc JL
Therapie; 1991; 46(4):293-303. PubMed ID: 1683024
[TBL] [Abstract][Full Text] [Related]
26. Apomorphine - pharmacological properties and clinical trials in Parkinson's disease.
Jenner P; Katzenschlager R
Parkinsonism Relat Disord; 2016 Dec; 33 Suppl 1():S13-S21. PubMed ID: 27979722
[TBL] [Abstract][Full Text] [Related]
27. Use of apomorphine in Parkinson's disease.
O'Sullivan JD; Lees AJ
Hosp Med; 1999 Nov; 60(11):816-20. PubMed ID: 10707193
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence.
Borgemeester RW; Lees AJ; van Laar T
Parkinsonism Relat Disord; 2016 Jun; 27():35-40. PubMed ID: 27132157
[TBL] [Abstract][Full Text] [Related]
29. Apomorphine in dopaminergic therapy.
Subramony JA
Mol Pharm; 2006; 3(4):380-5. PubMed ID: 16889431
[TBL] [Abstract][Full Text] [Related]
30. The role of apomorphine SL in the treatment of male erectile dysfunction.
Heaton JP; Altwein JE
BJU Int; 2001 Oct; 88 Suppl 3():36-8. PubMed ID: 11578278
[No Abstract] [Full Text] [Related]
31. Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.
Widnell KL; Comella C
Mov Disord; 2005; 20 Suppl 11():S30-7. PubMed ID: 15822107
[TBL] [Abstract][Full Text] [Related]
32. Apomorphine hydrochloride for the treatment of Parkinson's disease.
Unti E; Ceravolo R; Bonuccelli U
Expert Rev Neurother; 2015; 15(7):723-32. PubMed ID: 26037961
[TBL] [Abstract][Full Text] [Related]
33. On demand therapy for Parkinson's disease patients: Opportunities and choices.
Hauser RA; LeWitt PA; Comella CL
Postgrad Med; 2021 Sep; 133(7):721-727. PubMed ID: 34082655
[TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
Fox SH; Chuang R; Brotchie JM
Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.
Grandas F
Expert Rev Neurother; 2013 Dec; 13(12):1343-53. PubMed ID: 24160681
[TBL] [Abstract][Full Text] [Related]
36. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
37. Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.
Priano L; Albani G; Calderoni S; Baudo S; Lopiano L; Rizzone M; Astolfi V; Cavalli R; Gasco MR; Fraschini F; Bergamasco B; Mauro A
Neurol Sci; 2002 Sep; 23 Suppl 2():S99-100. PubMed ID: 12548362
[TBL] [Abstract][Full Text] [Related]
38. Effect of low concentrations of apomorphine on parkinsonism in a randomized, placebo-controlled, crossover study.
Gunzler SA; Koudelka C; Carlson NE; Pavel M; Nutt JG
Arch Neurol; 2008 Feb; 65(2):193-8. PubMed ID: 18268187
[TBL] [Abstract][Full Text] [Related]
39. Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD.
Nutt JG; Carter JH
Neurology; 2000 Jan; 54(1):247-50. PubMed ID: 10636162
[TBL] [Abstract][Full Text] [Related]
40. Dopamine agonists.
Factor SA
Med Clin North Am; 1999 Mar; 83(2):415-43, vi-vii. PubMed ID: 10093586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
